Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive O2 Transfer Analysis From the Lung to Mitochondria of Inhaled Treprostinil in Interstitial Lung Disease Pulmonary Hypertension

NCT05564637 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05564637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05564637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive O2 Transfer Analysis From the Lung to Mitochondria of Inhaled Treprostinil in Interstitial Lung Disease Pulmonary Hypertension
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
March 13, 2023
Completion date
October 30, 2024
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adults, interstitial lung disease, pulmonary arterial hypertension